$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Continuous release pharmaceutical compositions 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/26
  • A61K-009/32
출원번호 US-0068760 (1987-06-29)
우선권정보 GB-0004734 (1981-02-16)
발명자 / 주소
  • Hutchinson Francis G. (Lymm GBX)
출원인 / 주소
  • Imperial Chemical Industries PLC (London GB2 03)
인용정보 피인용 횟수 : 267  인용 특허 : 0

초록

Pharmaceutical compositions, comprising a polylactide and a pharmacologically active, acid stable polypeptide, which when placed in an aqueous physiological environment release the polypeptide at an approximately constant rate in an essentially monophasic manner, with a minimal, or no induction peri

대표청구항

A pharmaceutical composition comprising (a) from 50% to 99.999% of a polylactide which is a polymer of lactic acid alone, a copolymer of lactic acid and glycolic acid wherein the ratio of glycolide to lactide units is from 0 up to 3:1, a mixture of such polymers, a mixture of such copolymers, or a m

이 특허를 인용한 특허 (267) 인용/피인용 타임라인 분석

  1. Pham, Chiem V., Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content.
  2. Pham,Chiem V., Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content.
  3. Chiem V. Pham, Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content.
  4. Loughman Thomas Ciaran,IEX ; Russell Ruth Mary,IEX ; Touraud Franck Jean-Claude,FRX, Acidic polylactic polymers.
  5. Curran, William V.; Liu, Christopher M.; Bombardier, Amy C. D.; Leese, Richard A.; Hwang, You Seok; Lippa, Blaise S.; Zhang, Yanzhi, Antibiotic compositions for the treatment of gram negative infections.
  6. Leese, Richard A., Antibiotic compositions for the treatment of gram negative infections.
  7. Wang,Elizabeth A.; Wozney,John M.; Rosen,Vicki A., BMP products.
  8. Miyaji,Tatsuaki; Sato,Makoto; Murayama,Tamaki; Hoashi,Yohei; Saito,Hisae; Okada,Takao; Imamura,Yukari; Fujiyama,Yoshimichi, Bioabsorbable pharmaceutical formulation.
  9. Donovan, Stephen, Biodegradable botulinum toxin implant.
  10. Athanasiou Kyriacos A. ; Boyan Barbara D., Biodegradable implant.
  11. Wise Donald L. ; Gresser Joseph D. ; Trantolo Debra J. ; Hsu Yung-Yueh, Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same.
  12. Leban Johann J. (Kittsee ATX) Kull Frederick C. (Durham NC), Bombesin antagonists.
  13. Donovan, Stephen, Botulinum toxin formulation for oral administration.
  14. Li,Rebecca H.; Seeherman,Howard, Calcium phosphate delivery vehicles for osteoinductive proteins.
  15. Thompson, Bradley G.; Weiss, Samuel; Shingo, Tetsuro, Combined regulation of neural cell production.
  16. Lee Hye-Jung ; Johnson OluFunmi L. ; Zale Stephen E. ; Tracy Mark A., Composition and method using solid-phase particles for sustained in vivo release of a biologically active agent.
  17. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Composition for administering an NMDA receptor antagonist to a subject.
  18. Johnson OluFunmi Lily (Cambridge MA) Ganmukhi Medha M. (Wexford PA) Bernstein Howard (Cambridge MA) Auer Henry (Belmont MA) Khan M. Amin (Dowington PA), Composition for sustained release of human growth hormone.
  19. Johnson OluFunmi Lily ; Ganmukhi Medha M. ; Bernstein Howard ; Auer Henry ; Khan M. Amin, Composition for sustained release of human growth hormone.
  20. Johnson OluFunmi Lily ; Ganmukhi Medha M. ; Bernstein Howard ; Auer Henry ; Khan M. Amin, Composition for sustained release of human growth hormone.
  21. OluFunmi Lily Johnson ; Medha M. Ganmukhi ; Howard Bernstein ; Henry Auer ; M. Amin Khan, Composition for sustained release of human growth hormone.
  22. Zale Stephen E. (Hopkington MA) Burke Paul A. (Medford MA) Bernstein Howard (Cambridge MA) Brickner Avram (Brookline MA), Composition for sustained release of non-aggregated erythropoietin.
  23. Zale Stephen E. ; Burke Paul A. ; Bernstein Howard ; Brickner Avram, Composition for sustained release of non-aggregated erythropoietin.
  24. Clancy,Brian; Pittman,Debra; Seeherman,Howard, Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins.
  25. Gadek, Thomas; Burnier, John, Compositions and methods for treatment.
  26. Gadek, Thomas; Burnier, John; Zhong, Min; Shen, Wang; Oslob, Johan D.; Barr, Kenneth, Compositions and methods for treatment.
  27. Oslob, Johan; Shen, Wang; Barr, Kenneth; Zhong, Min, Compositions and methods for treatment.
  28. Oslob, Johan; Shen, Wang; Barr, Kenneth; Zhong, Min, Compositions and methods for treatment.
  29. Zhong, Min; Shen, Wang; Oslob, Johan D.; Barr, Kenneth, Compositions and methods for treatment.
  30. Zhong, Min; Shen, Wang; Oslob, Johan D.; Barr, Kenneth, Compositions and methods for treatment.
  31. Gadek, Thomas; Burnier, John, Compositions and methods for treatment of eye disorders.
  32. Wright, Jeremy C.; Tamraz, Wilma; Leonard, John J.; Gibson, John W.; Branham, Keith E.; Sjobeck, Stefania; Boyd, Brooks; Rubino, Christopher M., Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material.
  33. Wright, Jeremy C.; Tamraz, Wilma; Leonard, John J.; Gibson, John W.; Branham, Keith E.; Sjobeck, Stefania; Boyd, Brooks; Rubino, Christopher M., Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material.
  34. Cleland, Jeffrey L.; Lim, Amy; Powell, Michael Frank, Compositions for microencapsulation of antigens for use as vaccines.
  35. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Compositions for the treatment of CNS-related conditions.
  36. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Compositions for the treatment of CNS-related conditions.
  37. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  38. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  39. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  40. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  41. Weiss, Samuel; Gregg, Christopher; Davidoff, Allen; Tucker, Joseph, Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents.
  42. Thanoo Bagavathikanun Chithambara ; Murtagh James, Continuous microsphere process.
  43. Camble, Roger; Timms, David; Wilkinson, Anthony J., Continuous release pharmaceutical compositions.
  44. Hutchinson Francis G. (Lymm GBX), Continuous release pharmaceutical compositions formed by freeze drying acetic acid solutions of polylactide.
  45. Athanasiou Kyriacos A ; Boyan Barbara D, Continuous release polymeric implant carrier.
  46. Verity, A. Neil, Controlled delivery system.
  47. Verity, A. Neil, Controlled delivery system.
  48. Verity, A. Neil, Controlled delivery system.
  49. Verity, A. Neil, Controlled delivery system.
  50. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
  51. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
  52. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
  53. Yamamoto,Kazumichi; Yamada,Akiko; Hata,Yoshio, Controlled release composition and method of producing the same.
  54. Chandrashekar Bhagya L. ; Zhou Mingxing ; Jarr Eileen M. ; Dunn Richard L., Controlled release liquid delivery compositions with low initial drug burst.
  55. Hosei Shinoda JP; Yukiko Asou JP; Hiroaki Tamatani JP, Copolymer and process for preparing the same.
  56. Burnier, John, Crystalline pharmaceutical and methods of preparation and use thereof.
  57. Burnier, John, Crystalline pharmaceutical and methods of preparation and use thereof.
  58. Burnier, John, Crystalline pharmaceutical and methods of preparation and use thereof.
  59. Burnier, John, Crystalline pharmaceutical and methods of preparation and use thereof.
  60. Burnier, John; Gadek, Thomas; Naud, Frederic, Crystalline pharmaceutical and methods of preparation and use thereof.
  61. Burnier, John; Gadek, Thomas; Naud, Frederic, Crystalline pharmaceutical and methods of preparation and use thereof.
  62. Wozney,John M.; Celeste,Anthony J.; Thies,R. Scott; Yamaji,Noboru, DNA molecules encoding BMP receptor proteins.
  63. Sanders Lynda M. (Palo Alto CA) Burns ; Jr. Ramon A. (San Jose CA), Delivery systems for the controlled administration of LHRH analogs.
  64. Wright, Jeremy C.; Theeuwes, Felix; Gibson, John W.; Branham, Keith E.; Sjobeck, Stefania, Depot formulations.
  65. Lee, Elaine; Abrams, Robert, Device and method for treatment of a vascular defect.
  66. Weiss, Samuel; Gregg, Christopher, Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders.
  67. Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL), Drug delivery system and method of making the same.
  68. Kaplan, Edward J., Flexible and/or elastic brachytherapy seed or strand.
  69. Kaplan, Edward J., Flexible and/or elastic brachytherapy seed or strand.
  70. Kaplan, Edward J., Flexible and/or elastic brachytherapy seed or strand.
  71. Braden, Arthur R. C.; Vishwanatha, Jamboor K., Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics.
  72. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, Formulations and methods for providing prolonged local anesthesia.
  73. Charles B. Berde ; Robert S. Langer ; Joanne Curley ; Jenny Castillo, Formulations and methods for providing prolonged local anesthesia.
  74. Chasin Mark ; Sackler Richard ; Burch Ronald M. ; Goldenheim Paul ; Tigner Joseph, Formulations and methods for providing prolonged local anesthesia.
  75. Chasin, Mark; Goldenheim, Paul; Sackler, Richard; Tigner, Joseph; Burch, Ronald M, Formulations and methods for providing prolonged local anesthesia.
  76. Chasin, Mark; Sackler, Richard; Burch, Ronald M.; Goldenheim, Paul; Tigner, Joseph, Formulations and methods for providing prolonged local anesthesia.
  77. Chasin, Mark; Sackler, Richard; Burch, Ronald M.; Goldenheim, Paul; Tigner, Joseph, Formulations and methods for providing prolonged local anesthesia.
  78. Dwyer, John; Bray, Brian L.; Schneider, Stephen E.; Zhang, Huyi; Tvermoes, Nicolai A.; Johnston, Barbara E.; Friedrich, Paul E., HIV fusion inhibitor peptides with improved biological properties.
  79. Dwyer,John; Bray,Brian L.; Schneider,Stephen E.; Zhang,Huyi; Tvermores,Nikolai A.; Johnston,Barbara E.; Friedrich,Paul E., HIV fusion inhibitor peptides with improved biological properties.
  80. Lecuivre, Julie; Ladet, Sebastien, Hernia prosthesis.
  81. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, High load formulations and methods for providing prolonged local anesthesia.
  82. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, High load formulations and methods for providing prolonged local anesthesia.
  83. Tipton Arthur J. ; Holl Richard J., High viscosity liquid controlled delivery system.
  84. Gibson, John W.; Miller, Stacey S.; Middleton, John C.; Tipton, Arthur J., High viscosity liquid controlled delivery system and medical or surgical device.
  85. Gibson,John W.; Tipton,Arthur J., High viscosity liquid controlled delivery system and medical or surgical device.
  86. John W. Gibson ; Stacey A. Sullivan ; John C. Middleton ; Arthur J. Tipton, High viscosity liquid controlled delivery system and medical or surgical device.
  87. Tipton Arthur J., High viscosity liquid controlled delivery system as a device.
  88. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids.
  89. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids.
  90. Dayton, Christopher L. G.; Barton, Nelson; Bueno, Analia; Cuenca, Joslin G.; Hitchman, Tim; Kline, Katie A.; Lyon, Jonathan; Miller, Mark L.; Wall, Mark A., Hydrolases, nucleic acids encoding them and methods for making and using them.
  91. Dayton, Christopher L. G.; Barton, Nelson; Bueno, Analia; Cuenca, Joslin G.; Hitchman, Tim; Kline, Katie A.; Lyon, Jonathan; Miller, Mark L.; Wall, Mark A., Hydrolases, nucleic acids encoding them and methods for making and using them.
  92. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for making and using them.
  93. Hitchman, Tim; Dayton, Christopher L. G.; Kline, Katie A.; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for making and using them.
  94. Hitchman, Timothy; Dayton, Christopher L. G.; Kline, Katie A.; Lyon, Jonathan; Wall, Mark; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for making and using them.
  95. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for making and using them for biocatalytic synthesis of a structured lipid.
  96. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods to produce triglycerides.
  97. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods to produce triglycerides.
  98. Elachchabi, Amin; Stopek, Joshua; Broom, Daniel, Implantable devices including a film providing folding characteristics.
  99. Stopek, Joshua; Elachchabi, Amin; Broom, Daniel; Ebersole, Garrett; Witherell, Ryan, Implantable devices including a mesh and a pivotable film.
  100. Stopek, Joshua; Elachchabi, Amin; Broom, Daniel, Implantable film/mesh composite.
  101. Stopek, Joshua; Elachchabi, Amin; Broom, Daniel, Implantable film/mesh composite.
  102. Stopek, Joshua; Elachchabi, Amin; Broom, Daniel, Implantable film/mesh composite for passage of tissue therebetween.
  103. Stopek, Joshua; Elachchabi, Amin, Implantable polymeric films.
  104. Stricker Herbert (Neckargemund DEX) Entenmann Gunther (Ingelheim am Rhein DEX) Kern Otto (Ingelheim am Rhein DEX) Mikhail Michel (Ingelheim am Rhein DEX) Zierenberg Bernd (Bingen DEX), Implantable, biodegradable system for releasing active substance.
  105. Li, Rebecca; Seeherman, Howard; Kim, Hyun, Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins.
  106. Li, Rebecca; Seeherman, Howard; Kim, Hyun, Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins.
  107. Kim,Hyun; Li,Rebecca; Pavesio,Alessandra; Callegaro,Lanfranco; Seeherman,Howard; Wozney,John, Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins.
  108. Wright, Jeremy C.; Tamraz, Wilma; Leonard, John J.; Gibson, John W.; Branham, Keith E.; Sjobeck, Stefania; Boyd, Brooks; Rubino, Christopher M., Injectable controlled release composition comprising high viscosity liquid carrier.
  109. Shalaby Shalaby W. ; Jackson Steven A. ; Ignatious Francis ; Moreau Jacques-Pierre, Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides.
  110. Shalaby W. Shalaby ; Steven A. Jackson ; Francis X. Ignatious ; Jacques-Pierre Moreau ; Ruth M. Russell IE, Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides.
  111. Shalaby, Shalaby W.; Jackson, Steven A.; Ignatious, Francis X.; Moreau, Jacques-Pierre; Russell, Ruth M., Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides.
  112. Shalaby,Shalaby W.; Russell,Ruth M.; Moreau,Jacques Pierre; Jackson,Steven A.; Ignatious,Francis X., Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides.
  113. Shalaby Shalaby W. ; Jackson Steven A. ; Moreau Jacques-Pierre, Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides.
  114. Shalaby Shalaby Wahba ; Jackson Steven A. ; Moreau Jacques-Pierre, Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides.
  115. Shalaby, Shalaby Wahba; Jackson, Steven A.; Moreau, Jacques-Pierre, Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides.
  116. Zeller, James Robert; Venkatraman, Sripathy; Brot, Elisabeth C. A.; Iyer, Subashree; Hall, Michael, LFA-1 inhibitor and methods of preparation and polymorph thereof.
  117. Zeller, James Robert; Venkatraman, Sripathy; Brot, Elisabeth C. A.; Iyer, Subashree; Hall, Michael, LFA-1 inhibitor and methods of preparation and polymorph thereof.
  118. Yamamoto, Kohei; Tani, Tsutomu; Aoki, Takashi; Hata, Yoshio, Lactic acid polymer and process for producing the same.
  119. Ignatious, Francis X., Lactone bearing absorbable polymers.
  120. Ignatious,Francis X., Lactone bearing absorbable polymers.
  121. Dunn, Richard L., Low viscosity liquid polymeric delivery system.
  122. Reinprecht, Jon T.; Gleiman, Seth; Elachchabi, Amin; Witherell, Ryan; Stopek, Joshua; Ebersole, Garrett, Medical device films.
  123. Stopek, Joshua; Elachchabi, Amin; Broom, Daniel, Medical device with intrapore films.
  124. Stopek, Joshua; Elachchabi, Amin; Broom, Daniel, Medical device with intrapore films.
  125. Emperaire,Jean Claude, Medicaments for initiating ovulation.
  126. Bagavathikanun Chithambara Thanoo ; James Murtagh, Method and apparatus for formulating microspheres and microcapsules.
  127. Thanoo Bagavathikanun Chithambara ; Murtagh James, Method and apparatus for formulating microspheres and microcapsules.
  128. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Method and composition for administering an NMDA receptor antagonist to a subject.
  129. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Method and composition for administering an NMDA receptor antagonist to a subject.
  130. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Method and composition for administering an NMDA receptor antagonist to a subject.
  131. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Method for administering an NMDA receptor antagonist to a subject.
  132. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Method for administering an NMDA receptor antagonist to a subject.
  133. Cleland Jeffrey L. ; Jones Andrew J. S. ; Powell Michael Frank, Method for drying microspheres.
  134. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Method for producing microcapsule.
  135. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Method for producing microcapsule.
  136. Shirley, Bret; Hora, Maninder; O'Hagan, Derek; Singh, Manmohan, Method for producing sustained-release formulations.
  137. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  138. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  139. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  140. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  141. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  142. Janoff Andrew S. (Yardley PA) Cullis Pieter R. (Vancouver CAX) Bally Marcel B. (Vancouver CAX) Fountain Michael W. (Griggstown NJ) Ginsberg Richard S. (Monroe NJ) Hope Michael J. (Vancouver CAX) Madd, Method of dehydrating liposomes using protective sugars.
  143. Ohta,Shigeki; Weiss,Samuel, Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (PACAP).
  144. K?ndig, Thomas M.; Simard, John J. L., Method of inducing a CTL response.
  145. Kundig,Thomas M.; Simard,John L., Method of inducing a CTL response.
  146. Kündig, Thomas M.; Simard, John J. L., Method of inducing a CTL response.
  147. K��ndig,Thomas M.; Simard,John J. L., Method of inducing a CTL response.
  148. Simons, Damien, Method of making a knit with barbs.
  149. Eswara Amruta R. ; Muni Neal ; Schneider F. Howard ; Mione Peter J., Methods and articles of manufacture for nicotine cessation and monitoring nicotine use.
  150. Zhang,Renwen; Peluso,Diane; Morris,Elisabeth, Methods and compositions for healing and repair of articular cartilage.
  151. Tracy, Mark A.; Scher, David S., Methods and compositions for the targeted delivery of biologically active agents.
  152. Tracy,Mark A.; Scher,David S., Methods and compositions for the targeted delivery of biologically active agents.
  153. Went, Gregory T.; Fultz, Timothy J., Methods and compositions for the treatment of CNS-related conditions.
  154. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Methods and compositions for the treatment of CNS-related conditions.
  155. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Methods and compositions for the treatment of CNS-related conditions.
  156. Staas, Jay K.; Tice, Thomas R.; Hudson, Bruce W.; Tipton, Arthur J., Methods for manufacturing delivery devices and devices thereof.
  157. Sackler, Richard S.; Goldenheim, Paul D.; Chasin, Mark; Burch, Ronald M.; Reder, Robert F.; Tigner, Joseph, Methods for providing safe local anesthesia.
  158. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Methods for the treatment of CNS-related conditions.
  159. Goodearl,Andrew; Stroobant,Paul; Minghetti,Luisa; Waterfield,Michael; Marchioni,Mark; Chen,Mario Su; Hiles,Ian, Methods for treating multiple sclerosis with GGF-related polypeptides.
  160. Goodearl Andrew,GBX ; Stroobant Paul,GBX ; Minghetti Luisa,ITX ; Waterfield Michael,GBX ; Marchioni Mark ; Chen Mario Su ; Hiles Ian,GBX, Methods for treating nervous system pathophysiologies using glial growth factors.
  161. Went, Gregory T.; Fultz, Timothy J.; McClure, Natalie, Methods of administering amantadine.
  162. Stopek, Joshua; Ebersole, Garrett; Elachchabi, Amin; Broom, Daniel, Methods of forming self-supporting films for delivery of therapeutic agents.
  163. Stopek, Joshua; Ebersole, Garrett; Elachchabi, Amin; Broom, Daniel, Methods of forming self-supporting films for delivery of therapeutic agents.
  164. Maloney, Kevin, Methods of treating inflammatory disorders using high concentration natalizumab compositions.
  165. Wang,Elizabeth; Wozney,John M.; Rosen,Vicki A., Methods of treatment of periodontal disease.
  166. Mark A. Tracy ; Kevin L. Ward ; David S. Scher ; J. Keith Johnson, Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins.
  167. Thompson William W. (Indianapolis IN), Microparticle compositions containing peptides, and methods for the preparation thereof.
  168. Donnelly, John J.; Denis-Mize, Kimberly S.; Ott, Gary S., Microparticle-based transfection and activation of dendritic cells.
  169. Donnelly, John J.; Denis-Mize, Kimberly S.; Ott, Gary S., Microparticle-based transfection and activation of dendritic cells.
  170. Bernstein Howard ; Zhang Yan ; Khan M. Amin ; Tracy Mark A., Modulated release from biocompatible polymers.
  171. Bernstein, Howard; Zhang, Yan; Khan, M. Amin; Tracy, Mark A., Modulated release from biocompatible polymers.
  172. Howard Bernstein ; Yan Zhang ; M. Amin Khan ; Mark A. Tracy, Modulated release from biocompatible polymers.
  173. Shen, Wang; Barr, Kenneth; Oslob, Johan D.; Zhong, Min, Modulators of cellular adhesion.
  174. Shen, Wang; Barr, Kenneth; Oslob, Johan D.; Zhong, Min, Modulators of cellular adhesion.
  175. Turos, Edward; Shim, Jeung-Yeop, Nanoparticles for drug-delivery.
  176. Saini, Rajesh K.; Todd, Bradley L., On-the fly coating of acid-releasing degradable material onto a particulate.
  177. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  178. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  179. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  180. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  181. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  182. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  183. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  184. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  185. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  186. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  187. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  188. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  189. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharamaceutical dosage forms.
  190. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  191. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  192. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  193. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  194. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  195. Emery, Daryll A.; Straub, Darren E., Ovo delivery of an immunogen containing implant.
  196. Leese, Richard A.; Francis, Noreen; Curran, William V.; Borders, Donald B.; Jarolmen, Howard, Peptide antibiotics and methods for making same.
  197. Arvinte, Tudor; Schote, Uwe Thomas; Sigg, Juergen, Pharmaceutical compositions comprising TGF-beta.
  198. Weiss, Samuel; Enwere, Emeka; Andersen, Linda; Gregg, Christopher, Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis.
  199. Loomis Gary L. (Drexel Hill PA) Murdoch Joseph R. (Wilmington DE), Polylactide compositions.
  200. Loomis Gary L. (Drexel Hill PA) Murdoch Joseph R. (Wilmington DE), Polylactide compositions.
  201. Totakura Nagabhushanam (North Haven CT) Shalaby Shalaby W. (Anderson SC), Polymeric composition.
  202. Dunn, Richard L.; Garrett, John Steven; Ravivarapu, Harish; Chandrashekar, Bhagya L., Polymeric delivery formulations of leuprolide with improved efficacy.
  203. Gibson, John W.; Tipton, Arthur J., Polymeric device for controlled release of active agents.
  204. Gibson, John W.; Tipton, Arthur J., Polymeric devices for controlled release of active agents.
  205. Gregg, Christopher; Weiss, Samuel, Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin.
  206. Gregg, Christopher; Weiss, Samuel, Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin.
  207. Loughman, Thomas Ciaran, Process for making absorbable microparticles.
  208. Yanagisawa Norio,JPX ; Murayama Toshikazu,JPX ; Yokomori Yorozu,JPX ; Kimura Yoshiharu,JPX ; Tsuzaki Nobuko,JPX, Process for producing polyhydroxycarboxylic acid.
  209. Shingo, Tetsuro; Weiss, Samuel, Prolactin induced increase in neural stem cell numbers.
  210. Shingo,Tetsuro; Weiss,Samuel, Prolactin induced increase in neural stem cell numbers.
  211. Goldenheim Paul ; Lacouture Peter ; Donigi-Gale Donna ; Chasin Mark ; Sackler Richard, Prolonged anesthesia in joints and body spaces.
  212. Goldenheim, Paul; Donigi-Gale, Donna; Sackler, Richard; Lacouture, Peter; Chasin, Mark, Prolonged anesthesia in joints and body spaces.
  213. Sackler Richard ; Goldenheim Paul ; Chasin Mark, Prolonged local anesthesia with colchicine.
  214. Gombotz Wayne ; Pettit Dean ; Pankey Susan, Prolonged release of GM-CSF.
  215. Gombotz Wayne ; Pettit Dean ; Pankey Susan ; Lawter James Ronald ; Huang W. James, Prolonged release of GM-CSF.
  216. Gombotz Wayne R. ; Pettit Dean K. ; Pankey Susan C., Prolonged release of GM-CSF.
  217. Meneghin, Alfredo; Bourges, Xavier; Lecuivre, Julie, Prosthesis having a radiopaque element.
  218. Stewart, Daren L.; Lovoi, Paul A.; Rusch, Thomas W.; Lim, Alex; Francescatti, Darius, Radiation treatment using x-ray source.
  219. Stewart, Daren L.; Lovoi, Paul A.; Rusch, Thomas W.; Lim, Alex; Francescatti, Darius, Radiation treatment using x-ray source.
  220. Israel, David; Wolfman, Neil M., Recombinant bone morphogenetic protein heterodimers, compositions and methods of use.
  221. Hutchinson Francis Gowland,GB2, Salts of peptides with carboxy-terminated polyesters.
  222. Hutchinson Francis Gowland,GBX, Salts of peptides with carboxy-terminated polyesters.
  223. Stopek, Joshua; Broom, Daniel; Elachchabi, Amin; Casasanta, Thomas; Ebersole, Garrett, Self-detachable medical devices.
  224. Stopek, Joshua; Ebersole, Garrett; Elachchabi, Amin; Broom, Daniel, Self-supporting films for delivery of therapeutic agents.
  225. Cavanak Thomas,CHX ; Harris Alan,CHX, Somatostatin analogue composition and use in treating breast cancer.
  226. Poe, III, Bobby Gene; Huisinga, Jared Randall, Spray dried compositions and methods of use.
  227. Poe, III, Bobby Gene; Huisinga, Jared Randall, Spray dried compositions and methods of use.
  228. Abraham J. Domb IL; Zeev Zehavi IL, Stereocomplex polymeric carriers for drug delivery.
  229. Orsolini Piero,CHX ; Mauvernay Rolland-Yves,CHX ; Deghenghi Romano,CHX, Sustained and controlled release of water insoluble polypeptides.
  230. Dadey, Eric; Li, Qi; Lindemann, Christopher, Sustained delivery formulations of risperidone compounds.
  231. Silvestri Loui J. (Miramar FL) Pyle H. Ruth (Ft. Lauderdale FL), Sustained release dosage form.
  232. Ruiz Jean-Marc,FRX, Sustained release drug formulations.
  233. Bodmer David (Klingnau CHX) Fong Jones W. (Parsippany NJ) Kissel Thomas (Staufen DEX) Maulding Hawkins V. (Mendham NJ) Nagele Oskar (Sissach CHX) Pearson Jane E. (Ogendensburg NJ), Sustained release formulations of water soluble peptides.
  234. Bodmer David (Klingnau CHX) Fong Jones W. (Parsippany NJ) Kissel Thomas (Staufen DEX) Maulding Hawkins V. (Mendham NJ) Nagele Oskar (Sissach CHX) Pearson Jane E. (Ogendensburg NJ), Sustained release formulations of water soluble peptides.
  235. Bodmer David,CHX ; Fong Jones W. ; Kissel Thomas,DEX ; Maulding Hawkins V. ; Nagele Oskar,CHX ; Pearson Jane E., Sustained release formulations of water soluble peptides.
  236. Ignatious, Francis Xavier; Loughman, Thomas Ciaran; Shalaby, Shalaby Wahba; Touraud, Franck Jean-Claude, Sustained release ionic conjugate.
  237. Ignatious,Francis Xavier; Loughman,Thomas Ciaran; Shalaby,Shalaby Wahba; Touraud,Franck Jean Claude, Sustained release ionic conjugate.
  238. Ignatious,Francis Xavier; Loughman,Thomas Ciaran; Shalaby,Shalaby Wahba; Touraud,Franck Jean Claude, Sustained release ionic conjugate.
  239. Dunn, Richard L., Sustained release polymer.
  240. Dunn, Richard L., Sustained release polymer.
  241. Dunn, Richard L., Sustained release polymer.
  242. Dunn, Richard L., Sustained release polymer.
  243. Dunn, Richard L., Sustained release polymer.
  244. Dunn, Richard L., Sustained release polymer.
  245. Luk, Andrew S.; Junnarkar, Gunjan H.; Chen, Guohua, Sustained release small molecule drug formulation.
  246. Luk, Andrew S.; Junnarkar, Gunjan H.; Chen, Guohua, Sustained release small molecule drug formulation.
  247. Luk, Andrew S.; Junnarkar, Gunjan H.; Chen, Guohua, Sustained release small molecule drug formulation.
  248. Hosei Shinoda JP; Yukiko Asou JP; Hiroaki Tamatani JP, Sustained releasing drug comprising copolymers and process for preparing the same.
  249. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
  250. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
  251. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
  252. Kamei Shigeru,JPX ; Igari Yasutaka,JPX ; Ogawa Yasuaki,JPX, Sustained-release preparation.
  253. Kamei, Shigeru; Igari, Yasutaka; Ogawa, Yasuaki, Sustained-release preparation.
  254. Kamei,Shigeru; Igari,Yasutaka; Ogawa,Yasuaki, Sustained-release preparation.
  255. Aliani, Maqbool; Garcia, Ismael; Kovacevic, Ante, System and method for partially count-based allocation of vocoder resources.
  256. Celeste,Anthony J.; Wozney,John M.; Rosen,Vicki A.; Wolfman,Neil M.; Thomsen,Gerald H.; Melton,Douglas A., Tendon-inducing compositions.
  257. Celeste,Anthony J.; Wozney,John M.; Rosen,Vicki A.; Wolfman,Neil M.; Thomsen,Gerald H.; Melton,Douglas A., Tendon-inducing methods.
  258. Yum, Su II; Kwon, Sung Yun; Song, Xiaoping; Brown, James E., Transdermal delivery systems.
  259. Bailly, Pierre; Romuald, Gaëtan, Umbilical hernia prosthesis.
  260. Filvaroff,Ellen H.; Okumu,Franklin W., Use of insulin for the treatment of cartilaginous disorders.
  261. Kenney, Matthew; Kannan, Vinayagam, Vasopressin formulations for use in treatment of hypotension.
  262. Kenney, Matthew; Kannan, Vinayagam; Vandse, Sunil; Sanghvi, Suketu, Vasopressin formulations for use in treatment of hypotension.
  263. Buchanan, Christina Maree; Cooper, Garth James Smith, Vesiculins.
  264. Zaremba, Wolfgang; Kauffold, Johannes; Friess, Wolfgang; Hoffmann, Kerstin; Yordanova, Yordanka, Veterinary pharmaceutical composition and use thereof.
  265. Gibson, John W.; Tipton, Arthur J.; Holl, Richard J.; Meador, Stacey, Zero-order prolonged release coaxial implants.
  266. Gibson, John W.; Tipton, Arthur J.; Holl, Richard; Meador, Stacey, Zero-order prolonged release coaxial implants.
  267. Wild Hanno,DEX ; Hanko Rudolf,DEX ; Dorschug Michael,DEX ; Horlein Hans-Dietrich,DEX ; Beunink Jurgen,DEX ; Apeler Heiner,DEX ; Wehlmann Hermann,DEX ; Sebald Walter,DEX, hIL-4 mutant proteins used as antagonists or partial agonists of human interleukin 4.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로